Korean Journal of Head & Neck Oncology (대한두경부종양학회지)

The Korean Society for Head and Neck Oncology (대한두경부종양학회)
권호 표지

A Case of Mantle Cell Lymphoma Involving the Parotid Gland and Upper Neck

이하선과 상경부에 동시 발생한 외투세포 림프종 1예

  • Kwak, Seul Gi (Department of Otolaryngology-Head and Neck Surgery, Veterans Health Service Medical Center) ;
  • Kim, Choon Dong (Department of Otolaryngology-Head and Neck Surgery, Veterans Health Service Medical Center) ;
  • Kim, Yoon Jung (Department of Pathology, Veterans Health Service Medical Center) ;
  • Kim, Seung Woo (Department of Otolaryngology-Head and Neck Surgery, Veterans Health Service Medical Center)
  • 곽슬기 (중앙보훈병원 이비인후과) ;
  • 김춘동 (중앙보훈병원 이비인후과) ;
  • 김윤정 (중앙보훈병원 병리과) ;
  • 김승우 (중앙보훈병원 이비인후과)
  • Received : 2015.03.04
  • Accepted : 2015.04.30
  • Published : 2015.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

The Mantle cell lymphoma(MCL) is a relatively rare subtype of malignant lymphoma characterized by chromosomal translocation t(11 ; 14)(q13 ; q32), positive response for CD5, and nuclear cyclin D1. It is account for an estimated 3-6% of all non-Hodgkin's lymphoma. The involvement of extra-nodal site is not uncommon, whereas salivary glands are rarely affected. It is more commonly occurred in men and old age and approximately 75% of cases are diagnosed with advanced stage. It is usually characterized by an aggressive clinical course, and the prognosis is poorer than other type of head and neck lymphoma. We recently encountered a 69-year-old female with mass in parotid tail and upper neck, and it was diagnosed as mantle cell lymphoma. We report the unique case with a review of literature.

Keywords

References

  1. Hitz F, Bargetzi M, Coqliatti S, Lohri A, Taverna C, Renner C, et al. Diagnosis and treatment of mantle cell lymphoma. Swiss Med Wkly. 2013 Nov 13;143:w13868. Available from: URL:http://www.smw.ch/content/smw-2013-13868.
  2. Ambinder AJ, Shenoy PJ, Nastoupil LJ, Flowers CR. Using primary site as a predictor of survival in mantle cell lymphoma. Cancer. 2013;119(8):1570-1577. https://doi.org/10.1002/cncr.27898
  3. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: A clinicopathologic study of 80 cases. Blood. 1997;89(6):2067-2078. https://doi.org/10.1182/blood.V89.6.2067
  4. Pilavaki M, Athanasiadou A, Iordanidis F, Karakozoglou T, Palladas P. Magnetic resonance imaging with pathological correlation in a case of mantle cell lymphoma of the parotid gland: A case report. J Med Case Rep. 2010 Mar 30;4:99. Available from: URL: http://www.jmedicalcasereports.com/content/4/1/99. https://doi.org/10.1186/1752-1947-4-99
  5. Yamada T, Goto N, Tsurumi H, Takata K, Sato Y, Yopshino T, et al. Mantle cell lymphoma with a unique pattern of CD5 expression: A case report with review of the literatures. Med Mol Morphol. 2014;47(3):169-175. https://doi.org/10.1007/s00795-013-0060-x
  6. Pileri SA, Falini B. Mantle cell lymphoma. Haematologica. 2009;94(11):1488-1492. https://doi.org/10.3324/haematol.2009.013359
  7. Park JB, Kwon JG, Oh JY, Han JM, Jung JT, Kim EY, et al. A case of mantle cell lymphoma presenting as a small intestinal stricture. Intest Res. 2012;10(3):300-304. https://doi.org/10.5217/ir.2012.10.3.300
  8. Nodit L, Bahler DW, Jacobs SA, Locker J, Swerdlow SH. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003;34(10):1030-1034. https://doi.org/10.1053/S0046-8177(03)00410-6
  9. Orchard J, Garand R, Davis Z, Babbage G, Sahota S, Matutes E, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, non-nodal disease. Blood. 2003 15;101(12):4975-4981. https://doi.org/10.1182/blood-2002-06-1864
  10. Ambinder AJ, Shenoy PJ, Nastoupil LJ, Flowers CR. Using primary site as a predictor of survival in mantle cell lymphoma. Cancer. 2013;119(8):1570-1577. https://doi.org/10.1002/cncr.27898
  11. Lai R, Medeiros LJ. Pathologic diagnosis of mantle cell lymphoma. Clin lymphoma. 2010;1(3):197-206.
  12. Hwang JY, Kim SW, Yang SC, Kim CD. Extraparotid warthin tumor in upper cervical lymph node accompanied by primary cervical tuberculosis. Otolaryngol Head Neck Surg. 2011;144(4):646-647. https://doi.org/10.1177/0194599811398187
  13. Choi KM, Yang SC, Kim SW. Two cases of extraparotid Warthin's tumor in lateral cervical region. Korean J Head Neck Oncol. 2010;26(2):232-235.
  14. Rajguru S, Kahl BS. Emerging therapy for the treatment of mantle cell lymphoma. J Natl Compr Canc Netw. 2014;12(9):1311-1318. https://doi.org/10.6004/jnccn.2014.0126
  15. Hoster E, Dreyling M, Klapper W, Gisselbrecht C, van Hoof A, Kluin-Nelemans HC, et al. A new prognostic index(MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111(2):558-565. https://doi.org/10.1182/blood-2007-06-095331
  16. Geisler CH, Kolstad A, Laurell A, Raty R, Jerkeman M, Eriksson M, et al. The Mantle cell lymphoma International Prognostic Index(MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood. 2010;115(8):1530-1533. https://doi.org/10.1182/blood-2009-08-236570